You are currently browsing the archives for 20 July 2017.
Displaying 1 entry.

Under the terms of the sale.

The parties also entered right into a multi-year platelet purchase contract pursuant to which HemaCare will sell to the American Crimson Cross a minimum of 7,000 devices of single donor platelets per agreement year. Because of the sale, HemaCare will effect a decrease in force of approximately 100 employees in California and Maine, and HemaCare will incur a third quarter charge of approximately $900,000 associated with this action.. American Red Cross acquires HemaCare’s crimson blood cell collection procedure assets HemaCare Corporation announced today that it all has already reached a definitive contract to sell certain assets of its Blood Services procedures to the American Red Cross.